Prostate Cancer Clinical Trials in Georgia

Cancer Type = Prostate Cancer

Cancer Type = Prostate Cancer

There are currently 34 active Prostate Cancer clinical trials in Georgia.
3.
A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb®22841 Monotherapy and in Combination With Pembrolizumab in Subjects With Selected Advanced Solid Tumors (DUET-4)
Cancer Type
Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Eye Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Melanoma, Pancreatic Cancer, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT03849469
Protocol IDs
XmAb22841-01
NCI-2019-02498
DUET-4
4.
A Phase 1 Study of ASP1951 in Subjects With Advanced Solid Tumors
Cancer Type
Lung Cancer, Prostate Cancer , Unknown Primary
NCI ID
NCT03799003
Protocol IDs
1951-CL-0101
NCI-2019-02414
6.
NCORP Trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Cancer Type
Prostate Cancer , Unknown Primary
NCI ID
NCT03706365
Protocol IDs
16598
NCI-2019-00897
I3Y-MC-JPCM
2016-004276-21
Treatment Sites (13)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Atlanta Cancer Care - Conyers
Conyers
404-303-3355
Atlanta Cancer Care - Cumming
Cumming
Renee Gaiter
770-205-5292 x1041
Atlanta Cancer Care - Decatur
Decatur
404-303-3355
Atlanta Cancer Care - Stockbridge
Jonesboro
Andrena Jefferson
678 466-2069
Atlanta Cancer Care - Tower
Atlanta
404-303-3355
Georgia Cancer Specialists - Athens
Athens
Cynthia Pirkle
Georgia Cancer Specialists - CenterPointe
Sandy Springs
Anila Lokhandwala
404-256-4777 ext 9242
Georgia Cancer Specialists - Macon-Coliseum
Macon
Sonia Hernandez
478-745-6130 x8152
Georgia Cancer Specialists - Stemmer
Decatur
Nina Patel
770-496-5555
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
7.
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Cancer Type
Prostate Cancer , Unknown Primary
NCI ID
NCT03395197
Protocol IDs
C3441021
NCI-2018-01651
TALAPRO-2
2017-003295-31
8.
A Phase II Study of Nivolumab Combined with Ipilimumab for Patients with Advanced Rare Genitourinary Tumors
Cancer Type
Adrenal Cancer, Bladder Cancer, Germ Cell Tumor, Penile Cancer, Prostate Cancer
NCI ID
NCT03333616
Protocol IDs
17-423
NCI-2018-00182
9.
NCORP Trial
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer
Cancer Type
Prostate Cancer , Unknown Primary
NCI ID
NCT03371719
Protocol IDs
NRG-GU006
NRG-GU006
NCI-2017-01268
Treatment Sites (15)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Atlanta Cancer Care - Conyers
Conyers
404-303-3355
Atlanta Cancer Care - Cumming
Cumming
Renee Gaiter
770-205-5292 x1041
Atlanta Cancer Care - Decatur
Decatur
404-303-3355
Atlanta Cancer Care - Stockbridge
Jonesboro
Andrena Jefferson
678 466-2069
Atlanta Cancer Care - Tower
Atlanta
404-303-3355
Georgia Cancer Specialists - Athens
Athens
Cynthia Pirkle
Georgia Cancer Specialists - CenterPointe
Sandy Springs
Anila Lokhandwala
404-256-4777 ext 9242
Georgia Cancer Specialists - Macon-Coliseum
Macon
Sonia Hernandez
478-745-6130 x8152
Georgia Cancer Specialists - Stemmer
Decatur
Nina Patel
770-496-5555
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
13.
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
Cancer Type
Prostate Cancer
NCI ID
NCT01436968
Protocol IDs
PrTK03
NCI-2012-01912
17.
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Cancer Type
Prostate Cancer , Unknown Primary
NCI ID
NCT03767244
Protocol IDs
CR108535
NCI-2019-04921
2018-001746-34
56021927PCR3011
2018-001746-34
18.
NCORP Trial
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
Cancer Type
Breast Cancer, Cervical Cancer, Lymphoma, Prostate Cancer
NCI ID
NCT03190291
Protocol IDs
WF-30917CD
WF-30917CD
WF-30917CD
NCI-2017-01840
Treatment Sites (1)
19.
Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes
Cancer Type
Prostate Cancer
NCI ID
NCT03762759
Protocol IDs
RAD4516-18
NCI-2018-02702
IRB00106863
21.
Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease following Docetaxel: The CHAARTED2 Trial
Cancer Type
Prostate Cancer , Unknown Primary
NCI ID
NCT03419234
Protocol IDs
EA8153
EA8153
NCI-2017-00389
22.
Efficacy of Massage and Touch Therapy for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors
Cancer Type
Prostate Cancer
NCI ID
NCT03187275
Protocol IDs
Winship4016-17
NCI-2017-00720
IRB00095260
24.
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer
Cancer Type
Prostate Cancer
NCI ID
NCT02766478
Protocol IDs
EU3129-15
NCI-2016-00400
IRB00086186
25.
Improving Health Literacy in African-American Prostate Cancer Patients
Cancer Type
Prostate Cancer
NCI ID
NCT03322891
Protocol IDs
HU-HEALTHLITERACY
NCI-2018-00842
IRB00091879
IRB00085616
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.